Senna silvestris
Senna silvestris · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Senna silvestris is a botanical species of significant interest due to its unique phytochemical profile. Research has specifically identified the presence of the chemical compound salsolinol within its biological structure. Investigations into its therapeutic potential often focus on the plant's leaves as the primary source of active constituents. Scientific studies utilize various preparations, including the ethanol fraction of leaves, to isolate these components. Furthermore, the use of hydro-alcoholic extracts provides a comprehensive method for exploring the plant's diverse chemical properties.
- Synonyms
- Cassia Silvestris
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Senna silvestris is a botanical species known by several distinct regional names. In certain areas, it is commonly referred to as Fedegoso-do-mato. Another frequent name used to identify this plant is Ponçada. These various labels reflect the diverse ways local communities interact with the species. Understanding these common names is essential for accurate identification in the field.
Sources: Catalogue of Life (COL)
Synonyms
Senna silvestris is a botanical species that is frequently identified by its alternative taxonomic name, Cassia silvestris. This synonymy exists because different classification systems have historically categorized the plant under different genera. While modern botanical nomenclature favors the Senna genus, researchers often encounter the Cassia designation in older scientific literature. Understanding this relationship is essential for anyone conducting detailed field studies or herbarium research. Recognizing both names ensures accuracy when tracking the plant's distribution and characteristics across various databases.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Senna silvestris is a distinct member of the kingdom Plantae. Within this vast biological realm, the species is classified under the class Equisetopsida. It belongs to the order Fabales, which connects it to a diverse group of flowering plants. Furthermore, it is nested within the family Fabaceae, a group known for its significant botanical importance. Ultimately, this plant is identified by its specific placement within the genus Senna.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Senna |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Senna silvestris is a plant species with an expansive distribution throughout much of South America. It is particularly widespread within Brazil, where it can be found spanning numerous diverse regions. Its presence is documented in the North, Northeast, and Southeast territories of the country. Additionally, the species thrives in the South and West-Central areas of the Brazilian landscape. This broad geographical range highlights the plant's ability to adapt to various environmental conditions across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Senna silvestris is a self-supporting species characterized by its distinct tree-like growth form. This robust plant typically reaches a maximum height of 10 meters in most environments. However, under optimal conditions, it can occasionally grow as tall as 12 meters. These physical dimensions make it a prominent feature within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Senna silvestris has emerged as a significant subject of pharmacological interest due to its potential antiviral properties. Recent research involving extracts from the Venezuelan Amazonian rain forest identified this specific species as an effective inhibitor of hepatitis B virus replication. Through a process of bioassay-guided purification, scientists successfully isolated the key active component within the plant's ethanol fraction. This specific compound was identified as salsolinol, which demonstrated the ability to inhibit both HBV DNA and core HBV DNA. While salsolinol is already utilized in traditional medicine, its discovery within this plant opens new doors for developing potent antiviral treatments.
Conditions
Senna silvestris demonstrates significant antiviral activity against the hepatitis B virus (HBV). Specifically, this plant species has been shown to exert inhibitory activity on HBV replication. Research indicates that the purified compounds derived from the plant effectively treat HBV DNA by inhibiting its presence. Furthermore, the plant's extracts demonstrate a specialized ability to treat core HBV DNA. These combined effects highlight the medicinal potential of Senna silvestris in managing various aspects of the HBV infection.
Preparations
Senna silvestris is prepared as hydro-alcoholic extracts to test for inhibitory activity against the hepatitis B virus. Researchers utilized these hydro-alcoholic extracts to identify species from the Venezuelan Amazonian rain forest that could impact HBV replication. Following these initial tests, Senna silvestris is prepared as an ethanol fraction of leaves to facilitate bioassay-guided purification. This specific ethanol fraction displayed the most significant inhibitory activity against the virus during the study. Through this preparation process, the compound salsolinol was eventually identified as the active antiviral agent.
Parts used
Senna silvestris has been identified as a significant plant species due to its potential antiviral properties. Researchers focused their investigation on the ethanol fraction of the leaves to isolate bioactive compounds. Through a process of bioassay-guided purification, the specific chemical salsolinol was successfully identified within these leaf extracts. This compound demonstrated a notable ability to inhibit the replication of the hepatitis B virus in laboratory settings. Consequently, the leaf of this plant serves as a vital source for discovering new therapeutic agents against viral infections.